Literature DB >> 20734114

Influence of permeant lipophilicity on permeation across human sclera.

He Wen1, Jinsong Hao, S Kevin Li.   

Abstract

PURPOSE: The objectives of this study were to determine the effects of permeant lipophilicity on permeant uptake into and transport across human sclera for transscleral delivery.
METHODS: Model permeants with a wide range of lipophilicities were selected and studied with human sclera. Uptake experiments were carried out to measure permeant partitioning into the sclera. Transport experiments were performed in side-by-side diffusion cells, and the permeability coefficients and transport lag times of the permeants across the sclera were evaluated.
RESULTS: Permeants with higher lipophilicity showed higher partition coefficients to human sclera, and the apparent transport lag time also increased significantly as the permeant lipophilicity increased. No correlation between the permeability coefficients and lipophilicity of the model permeants was observed in this study with human sclera. A hypothesis on the different findings between the present and previous studies was proposed.
CONCLUSIONS: Permeants with higher lipophilicity exhibited stronger binding to human sclera and would therefore lead to larger permeant partitioning to the sclera and longer transport lag time. The steady-state permeability coefficients of the permeants were not significantly affected by permeant lipophilicity.

Entities:  

Mesh:

Year:  2010        PMID: 20734114      PMCID: PMC2962700          DOI: 10.1007/s11095-010-0237-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.

Authors:  F Lombardo; M Y Shalaeva; K A Tupper; F Gao
Journal:  J Med Chem       Date:  2001-07-19       Impact factor: 7.446

Review 2.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

Authors:  M R Prausnitz; J S Noonan
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

3.  Liposomes as an ocular delivery system of fluconazole: in-vitro studies.

Authors:  Fawzia S Habib; Ehub A Fouad; Mohamed S Abdel-Rhaman; Dina Fathalla
Journal:  Acta Ophthalmol       Date:  2010-12       Impact factor: 3.761

Review 4.  Ophthalmic drug delivery systems--recent advances.

Authors:  C L Bourlais; L Acar; H Zia; P A Sado; T Needham; R Leverge
Journal:  Prog Retin Eye Res       Date:  1998-01       Impact factor: 21.198

5.  Mass transport phenomena and models: theoretical concepts.

Authors:  G L Flynn; S H Yalkowsky; T J Roseman
Journal:  J Pharm Sci       Date:  1974-04       Impact factor: 3.534

6.  Design, synthesis, and anticancer activity of phosphonic acid diphosphate derivative of adenine-containing butenolide and its water-soluble derivatives of paclitaxel with high antitumor activity.

Authors:  Ali A Moosavi-Movahedi; Shahram Hakimelahi; Jamshid Chamani; Ghadam Ali Khodarahmi; Farshid Hassanzadeh; Fen-Tair Luo; Tai Wei Ly; Kak-Shan Shia; Chi-Feng Yen; Moti L Jain; Ramasamy Kulatheeswaran; Cuihua Xue; Manijeh Pasdar; Gholam Hossein Hakimelahi
Journal:  Bioorg Med Chem       Date:  2003-10-01       Impact factor: 3.641

7.  Relation between retention factors of immunosuppressive drugs in microemulsion electrokinetic chromatography with biosurfactants and octanol-water partition coefficients.

Authors:  Silvia E Lucangioli; Ernst Kenndler; Adriana Carlucci; Valeria P Tripodi; Silvia L Scioscia; Clyde N Carducci
Journal:  J Pharm Biomed Anal       Date:  2003-12-04       Impact factor: 3.935

Review 8.  Fungal infections of the cornea.

Authors:  P A Thomas
Journal:  Eye (Lond)       Date:  2003-11       Impact factor: 3.775

9.  Structure and interaction of inhibitors with the TEA/H+ exchanger of rabbit renal brush border membranes.

Authors:  S H Wright; T M Wunz; T P Wunz
Journal:  Pflugers Arch       Date:  1995-01       Impact factor: 3.657

Review 10.  Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections.

Authors:  F N Vincent-Ballereau; O N Patey; C Lafaix
Journal:  Pharm Weekbl Sci       Date:  1991-04-26
View more
  6 in total

1.  MRI study of subconjunctival and intravitreal injections.

Authors:  S Kevin Li; Jinsong Hao; Hongshan Liu; Jing-huei Lee
Journal:  J Pharm Sci       Date:  2012-03-30       Impact factor: 3.534

2.  Hydrophilic prodrug approach for reduced pigment binding and enhanced transscleral retinal delivery of celecoxib.

Authors:  Pradip Malik; Rajendra S Kadam; Narayan P S Cheruvu; Uday B Kompella
Journal:  Mol Pharm       Date:  2012-02-08       Impact factor: 4.939

3.  Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab.

Authors:  He Wen; Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2012-12-04       Impact factor: 3.534

Review 4.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

5.  Design and development of artemisinin and dexamethasone loaded topical nanodispersion for the effective treatment of age-related macular degeneration.

Authors:  Chandrasekar Ponnusamy; Abimanyu Sugumaran; Venkateshwaran Krishnaswami; Ruckmani Kandasamy; Subramanian Natesan
Journal:  IET Nanobiotechnol       Date:  2019-10       Impact factor: 1.847

6.  Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab.

Authors:  Rini Rachel Joseph; Dulcia Wei Ni Tan; Moreno Raja Miguel Ramon; Jayaganesh V Natarajan; Rupesh Agrawal; Tina T Wong; Subbu S Venkatraman
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.